GSK Pharmaceuticals reports a temporary production disruption due to a fire at one of its contract manufacturing facilities; ...

With the stock's current price at Rs 2819.60, GlaxoSmithKline Pharmaceuticals is navigating through market dynamics, ...

ICICI Securities recommended reduce rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 2,600 in its research ...

The company is working closely with the contract manufacturing facility for resumption of operations. Shares of ...

Assistant Editor, Hannah Blake, picks this series back up, starting here with the history of GlaxoSmithKline. GlaxoSmithKline (GSK) is a science-led global healthcare company, which headquarters ...

Amazon and Samara Capital-backed supermarket chain More Retail is planning to raise around Rs 2,000 crore through an initial public offer (IPO), which is expected to hit the market in the calendar ...

GlaxoSmithKline Pharmaceuticals Ltd. reported a 36% increase in consolidated net profit to Rs 263 crore for the quarter ended ...

Witty began his career as a management trainee at Glaxo UK in 1985 and went on to hold several international leadership roles ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

India's GlaxoSmithKline Pharmaceuticals reported a higher fourth-quarter profit on Tuesday, led by steady demand for its ...

ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma's earnings are expected to see a CAGR of 15.3% over FY24-27.